Intranasal Adenovirus-Vectored Vaccine for Induction of Long-Lasting Humoral Immunity-Mediated Broad Protection against Influenza in Mice

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Virology

• Publication date

  2014-06-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.00823-14PMID 24920793PMCID PMC4136366
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies

  2013cited by this paper
• Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection

  2013cited by this paper
• Influenza virus hemagglutinin stalk-based antibodies and vaccines.

  2013cited by this paper
• Comprehensive chemical profiling of guizhi fuling capsule by the combined use of gas chromatography-mass spectrometry with a deconvolution software and rapid-resolution liquid chromatography quadrupole time-of-flight tandem mass spectrometry.

  2012cited by this paper
• Elicitation of Broadly Neutralizing Influenza Antibodies in Animals with Previous Influenza Exposure

  2012cited by this paper
• Sublingual Immunization with a Live Attenuated Influenza A Virus Lacking the Nonstructural Protein 1 Induces Broad Protective Immunity in Mice

  2012cited by this paper
• Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses

  2012cited by this paper
• Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes

  2012cited by this paper
• Intranasal Vaccination with Replication-Defective Adenovirus Type 5 Encoding Influenza Virus Hemagglutinin Elicits Protective Immunity to Homologous Challenge and Partial Protection to Heterologous Challenge in Pigs

  2012cited by this paper
• Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells.

  2011cited by this paper
• Cross-Reactive T Cells Are Involved in Rapid Clearance of 2009 Pandemic H1N1 Influenza Virus in Nonhuman Primates

  2011cited by this paper
• Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection

  2011cited by this paper
• A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

  2011cited by this paper
• Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity

  2011cited by this paper
• Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza

  2011cited by this paper
• Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice

  2011cited by this paper
• Comparative Efficacy of Hemagglutinin, Nucleoprotein, and Matrix 2 Protein Gene-Based Vaccination against H5N1 Influenza in Mouse and Ferret

  2010cited by this paper
• Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge

  2010cited by this paper
• Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination

  2010cited by this paper
• Induction of a Protective Heterosubtypic Immune Response Against the Influenza Virus by using Recombinant Adenoviral Vectors Expressing Hemagglutinin of the Influenza H5 Virus

  2010influential reference
• Prophylactic and Therapeutic Efficacy of Avian Antibodies Against Influenza Virus H5N1 and H1N1 in Mice

  2010cited by this paper
• Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain

  2010cited by this paper
• Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.

  2009cited by this paper
• M2e-based universal influenza A vaccine.

  2009cited by this paper
• A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses.

  2008cited by this paper
• Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice

  2008cited by this paper
• Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1

  2007cited by this paper
• The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.

  2007cited by this paper
• Complex Adenovirus-Mediated Expression of West Nile Virus C, PreM, E, and NS1 Proteins Induces both Humoral and Cellular Immune Responses

  2007cited by this paper
• Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization

  2006cited by this paper
• Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals

  2005cited by this paper
• Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

  2005cited by this paper
• Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans.

  2005cited by this paper
• Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.

  2004cited by this paper
• Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.

  2004cited by this paper
• Adenoviruses as vaccine vectors

  2004cited by this paper
• Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

  2003cited by this paper
• Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.

  2003cited by this paper
• Role of mucosal immunity in influenza.

  2003cited by this paper
• Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene.

  2001cited by this paper
• Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes.

  2001cited by this paper
• Development of a preventive vaccine for Ebola virus infection in primates

  2000cited by this paper
• Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues.

  1999cited by this paper
• A universal influenza A vaccine based on the extracellular domain of the M2 protein

  1999cited by this paper
• Modified M2 proteins produce heterotypic immunity against influenza A virus.

  1999cited by this paper
• Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection.

  1999cited by this paper
• Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein.

  1998cited by this paper
• Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.

  1997cited by this paper
• Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization

  1996cited by this paper
• Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein.

  1995cited by this paper
• A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains

  1993cited by this paper
• Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice

  1990cited by this paper
• Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

  1986cited by this paper
• Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity

  1983cited by this paper
• Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes.

  1982cited by this paper
• Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus.

  1975cited by this paper
• Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus.

  1975cited by this paper
• The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

  1972cited by this paper

• Single-dose intranasal AdC68-vectored vaccines rapidly protect Syrian hamsters against lethal Nipah virus infection.

  2025cites this paper
• Single-Dose Intranasal or Intramuscular Administration of Simian Adenovirus-Based H1N1 Vaccine Induces a Robust Humoral Response and Complete Protection in Mice

  2025cites this paper
• Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2.

  2024cites this paper
• Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination

  2023cites this paper
• Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants

  2023cites this paper
• Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2

  2023cites this paper
• Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses

  2021cites this paper
• SARS‐CoV‐2 nucleocapsid protein intranasal inoculation induces local and systemic T cell responses in mice

  2021cites this paper
• Elicitation of Highly Pathogenic Avian Influenza H5N1 M2e and HA2-Specific Humoral and Cell-Mediated Immune Response in Chicken Following Immunization With Recombinant M2e–HA2 Fusion Protein

  2021cites this paper
• Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial

  2021cites this paper
• Shell-mediated phagocytosis to reshape viral-vectored vaccine-induced immunity.

  2021cites this paper
• Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines

  2020cites this paper
• Recombinant Adenovirus Vectors as Mucosal Vaccines

  2020cites this paper
• Human antigen presenting cells stimulated with Salmonella delivered influenza antigens induce cytokine production and proliferation of human CD4+ T cells in vitro.

  2019cites this paper
• Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development

  2018cites this paper
• Flagellin FljB as an adjuvant to the recombinant adenovirus rabies glycoprotein vaccine increases immune responses against rabies in mice

  2017cites this paper
• An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice

  2017cites this paper
• Inter-Clade Protection Offered by Mw-Adjuvanted Recombinant HA, NP Proteins, and M2e Peptide Combination Vaccine in Mice Correlates with Cellular Immune Response

  2017cites this paper
• Evaluation of protective efficacy of three novel H3N2 canine influenza vaccines

  2017cites this paper
• Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice.

  2017cites this paper
• An Influenza HA and M2e Based Vaccine Delivered by a Novel Attenuated Salmonella Mutant Protects Mice against Homologous H1N1 Infection

  2017cites this paper
• Genetic Modification of the Lung Directed Toward Treatment of Human Disease

  2017cites this paper
• Adenoviral Vector Vaccines Antigen Transgene

  2016cites this paper
• Development of an Ad5H3 Chimera Using the “Antigen Capsid-Incorporation” Strategy for an Alternative Vaccination Approach

  2016cites this paper
• Combined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus

  2016cites this paper
• Strategies towards universal pandemic influenza vaccines

  2016cites this paper
• Baculovirus Displaying Hemagglutinin Elicits Broad Cross-Protection against Influenza in Mice

  2016cites this paper
• Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens

  2016cites this paper
• Mechanisms of cross-protection and development of universal influenza vaccines

  2015cites this paper
• The reoccurrence of H5N1 outbreaks necessitates the development of safe and effective influenza vaccine technologies for the prevention and control of avian influenza in Sub-Saharan Africa

  2015cites this paper
• Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challenge

  2015cites this paper
• Progress on adenovirus-vectored universal influenza vaccines

  2015cites this paper
• M2e-Based Universal Influenza A Vaccines

  2015cites this paper
• Development of a heat-stable and orally delivered recombinant M2e-expressing B. subtilis spore-based influenza vaccine

  2014cites this paper